Topotecan hydrochloride (Hycamtin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Topotecan hydrochloride (Hycamtin), covering 2016-01-14 to 2016-01-14. Get the full timeline:
Most recent: Clinical Trial Update: Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer [Phase 2]